This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Eastern Michigan University, University of Michigan. Active years: 2017-2025.
Company Filing History:
3 out of 31 
3 out of 3,525 
Years Active: 2017-2025
Title: The Innovative Contributions of Ashley Reinke
Introduction
Ashley Reinke is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of medical research, particularly in the development of compounds that target plasminogen activator inhibitor-1 (PAI-1). With a total of three patents to her name, Reinke's work is paving the way for advancements in the treatment of various diseases.
Latest Patents
Among her latest patents is the invention of plasminogen activator inhibitor-1 (PAI-1) inhibitor compounds and their methods of use. These compounds are designed to treat diseases or disorders associated with elevated PAI-1 levels. The disclosure includes applications for preventing or reducing thrombosis and fibrosis, promoting thrombolysis, and modulating lipid metabolism. This innovative approach aims to address health issues related to elevated PAI-1, cholesterol, or lipid levels.
Career Highlights
Reinke has worked with esteemed institutions such as the University of Michigan and Eastern Michigan University. Her experience in these research environments has allowed her to collaborate with leading experts in her field and contribute to groundbreaking studies.
Collaborations
Some of her notable coworkers include Daniel Lawrence and Cory Emal. Their collaborative efforts have further enhanced the impact of her research and innovations.
Conclusion
Ashley Reinke's contributions to medical research through her innovative patents highlight her role as a leading inventor in her field. Her work continues to inspire advancements in the treatment of diseases associated with elevated PAI-1 levels.